About
Company Management
Board of Directors
Scientific Advisory Board
Careers
Technology
Oncoprex Immunogene Therapy
Nanovesicle Delivery
Clinical Trials
Pipeline
Oncoprex Monotherapy
Erlotinib Combination
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
News
Press Releases
Media Coverage
Events
Videos
Email Alerts
Contact
About
Company Management
Board of Directors
Scientific Advisory Board
Careers
Technology
Oncoprex Immunogene Therapy
Nanovesicle Delivery
Clinical Trials
Pipeline
Oncoprex Monotherapy
Erlotinib Combination
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
News
Press Releases
Media Coverage
Events
Videos
Email Alerts
Contact
© 2019 Genprex Inc. All Rights Reserved.
Monthly Archives:
May 2010
SPORE Grants Turn Into Hope for Patients
May 4, 2010
SPORE Grants Turn Into Hope for Patients
Read More
Search for:
Categories
Conferences
Education
Industry News
Media Coverage
Press Releases
Recent Posts
A Potential NSCLC Treatment for Large Patient Populations
Genprex Provides Update on Development of its Oncoprex Immunogene Therapy in Combination With Immunotherapy for Non-Small Cell Lung Cancer
Genprex to Present at Sachs 5th Annual Immuno-Oncology BD&L and Investment Forum
Big Excitement in Gene Therapy at ASGCT 2019
Genprex Retains Addison Whitney for Drug Nomenclature Branding
Archives
July 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
October 2017
July 2017
April 2017
March 2017
January 2017
December 2016
November 2016
August 2016
May 2014
April 2012
September 2011
July 2011
June 2011
April 2011
May 2010
STAY IN THE KNOW WITH
EMAIL NEWS ALERTS
Don't miss out. Get our news delivered to your inbox.
Get Email News Alerts
